Diversify in foreign currency, while enjoying the simple convenience of an EverBank WorldCurrency CD or money market account. Step 1, choose your account type. Step 2, choose from our wide range of currencies, which includes all the major ones and some from emerging markets. It's that simple. Apply now.
Mergers Heat Up Between Haves, Have-Nots
by The Investment U Research Team
We spotlighted Pulte Homes (NYSE: PHM) along with a few other homebuilders yesterday as signs that the housing market is starting to move again. This morning we were greeted with the news that Pulte is buying out Centex (NYSE: CTX) for $10.50 a share – a 38% premium to it close yesterday.
Moving again indeed.
We’ve seen a number of mergers in the past quarter: Pfizer’s (NYSE: PFE) takeover of Wyeth (NYSE: WYE), Merck & Co’s (NYSE: MRK) merger with Schering-Plough (NYSE: SGP) and NRG Energy’s (NYSE: NRG) takeover of Calpine Corp (NYSE: CPN).
IBM (NYSE: IBM) pulled out of a planned merger on Monday after Sun Microsystem’s (Nasdaq: JAVA) board rejected its formal offer. It was a better deal for IBM, with Sun’s cash reserves and cheap asset prices.
But this doesn’t mean that we won’t be seeing large merger activity stop over the next few quarters. In fact, we’ll probably see a resurgence of them as the credit markets start to open up and the economics become clear in many industries.
The recession has created an interesting situation where there is a significant difference between the haves (those companies who have weathered the storm and are sitting on large cash reserves) and the have-nots, those that haven’t – and look appetizing for takeovers.
Companies with stable cash reserves are going to look at their weaker competition and see cheap ways to buy market share. And like the buyouts above, this activity can be an instant windfall for investors who get in early.
Companies mentioned in this article: PHM, CTX, PFE, WYE, MRK, SGP, NRG, CPN, IBM and JAVA.
- M&A = Movement & Action
- Look Who Just Showed Up to the Takeover Party
- The Coming Takeover Boom: 3 Sectors Ripe for Mergers & Acquisitions
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
One Response to “Mergers Heat Up Between Haves, Have-Nots”
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed
April 10th, 2009 at 11:57 am
I would like my fat check on May 15 thanks Tony
Reply